These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2619944)

  • 1. Clinical research in cancer: a time for consensus.
    Oldham RK
    Mol Biother; 1989; 1(5):242-3. PubMed ID: 2619944
    [No Abstract]   [Full Text] [Related]  

  • 2. Indirect costs on research grants and contracts.
    Tzagournis M
    Ohio Med; 1991 Dec; 87(12):576-7. PubMed ID: 1766634
    [No Abstract]   [Full Text] [Related]  

  • 3. Economic issues in defining stable funding levels for HIV/AIDS research.
    Eastaugh SR
    J Health Adm Educ; 1992; 10(1):139-49. PubMed ID: 10118035
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost analysis and consequences of the National Cancer Plan.
    Pekar PP
    Fed Proc; 1974 Nov; 33(11):2225-30. PubMed ID: 4430379
    [No Abstract]   [Full Text] [Related]  

  • 5. NIH cost analysis of a contract proposal.
    Payne MD
    Grants Mag; 1984 Mar; 7(1):70-80. PubMed ID: 10270262
    [No Abstract]   [Full Text] [Related]  

  • 6. Determining the costs of journals used in support of federally sponsored research.
    McKeehan NC
    Bull Med Libr Assoc; 1984 Apr; 72(2):147-9. PubMed ID: 6733324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Federal requirements for performing cost analysis of a contract proposal.
    Powers RJ
    Grants Mag; 1984 Mar; 7(1):65-70. PubMed ID: 10270261
    [No Abstract]   [Full Text] [Related]  

  • 8. The future of biomedical research.
    Gottschalk CW
    N C Med J; 1979 Aug; 40(8):501-4. PubMed ID: 291786
    [No Abstract]   [Full Text] [Related]  

  • 9. The cost of AIDS.
    Scitovsky AA; Rice DP
    Issues Sci Technol; 1987; 4(1):61-6. PubMed ID: 10312558
    [No Abstract]   [Full Text] [Related]  

  • 10. New estimates of drug development costs.
    Frank RG
    J Health Econ; 2003 Mar; 22(2):325-30. PubMed ID: 12606149
    [No Abstract]   [Full Text] [Related]  

  • 11. Budget and The National Cancer Program (NCP).
    Rauscher FJ
    Cancer Res; 1974 Jul; 34(7):1743-8. PubMed ID: 4833919
    [No Abstract]   [Full Text] [Related]  

  • 12. Strengthening biomedicine's roots.
    Dill KA
    Nature; 1999 Jul; 400(6742):309-10. PubMed ID: 10432104
    [No Abstract]   [Full Text] [Related]  

  • 13. An analysis of finder's fees in clinical research.
    Maher EA
    CMAJ; 1994 Jan; 150(2):252-6. PubMed ID: 8287347
    [No Abstract]   [Full Text] [Related]  

  • 14. Inventions and patents.
    Pieper B; Cleland V
    Nurs Res; 1991; 40(6):374-6. PubMed ID: 1956820
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer research and treatment. When money, morals, and medical science converge.
    Meyer CR
    Minn Med; 1996 Apr; 79(4):5. PubMed ID: 8637493
    [No Abstract]   [Full Text] [Related]  

  • 16. Costs of research and patent considerations.
    Vickery BH
    J Androl; 1987; 8(1):S27-32. PubMed ID: 3549653
    [No Abstract]   [Full Text] [Related]  

  • 17. Stopping a medical research project for financial reasons.
    Drueke TB; Descamps-Latscha B; Locatelli F
    Nephrol Dial Transplant; 2003 Oct; 18(10):1982-3. PubMed ID: 13679470
    [No Abstract]   [Full Text] [Related]  

  • 18. Health research at educational institutions: costs and accountability. The view from where the Department of HHS Inspector General sits.
    Lowe RB
    Fed Proc; 1980 Nov; 39(13):7a-10a. PubMed ID: 6775983
    [No Abstract]   [Full Text] [Related]  

  • 19. The indirect costs of sponsored research.
    Cooper AD
    Clin Res; 1984 Apr; 32(2):99-105. PubMed ID: 6713806
    [No Abstract]   [Full Text] [Related]  

  • 20. The price of innovation: new estimates of drug development costs.
    DiMasi JA; Hansen RW; Grabowski HG
    J Health Econ; 2003 Mar; 22(2):151-85. PubMed ID: 12606142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.